AP301 Efficacy and Safety in Chinese Dialysis Patients With Hyperphosphatemia

Clinical trial NCT07030595 · COMPLETED

Trial details

NCT number: NCT07030595
Sponsor: Alebund Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

ESRD (End Stage Renal Disease)Chronic Kidney Disease(CKD)Hyperphosphatemia Hyperphosphatemia in Chronic Kidney Disease Dialysis Chronic Kidney Disease, Receiving Dialysis

Start date: 2023-06-12
Primary completion: 2024-10-02
Enrollment: 474

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.